Tag: Biotechnology Award

Amir Abaas Momtazi-Borojeni | Biotechnology | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Amir Abaas Momtazi-Borojeni | Biotechnology | Best Researcher Award

Faculty Member from Neyshabur university of medical sciences, Iran

Dr. Amir Abbas Momtazi-Borojeni is an Assistant Professor of Medical Biotechnology at Neyshabur University of Medical Sciences in Iran. Born on September 17, 1985, in Isfahan, Iran, he has established a distinguished career in medical biotechnology, focusing on nanomedicine, immunotherapy, and phytomedicine. With over 160 publications and more than 7,000 citations, his research has significantly contributed to the fields of cardiovascular and metabolic diseases. His work on PCSK9-targeted therapies and nanoliposomal drug delivery systems has been recognized internationally. Dr. Momtazi-Borojeni’s interdisciplinary approach integrates molecular biology, pharmacology, and bioinformatics, reflecting his commitment to advancing medical science through innovative research.

Professional Profile​

Education

Dr. Momtazi-Borojeni’s academic journey began with a BSc in Biology from Isfahan University (2004–2008), followed by an MSc in Microbial Biotechnology from the same institution (2008–2010). He then pursued a Ph.D. in Medical Biotechnology at Mashhad University of Medical Sciences (2013–2019), where his research focused on developing nanoliposome-based vaccines targeting PCSK9 for lipid-lowering and anti-atherosclerotic effects. His doctoral work combined immunology, nanotechnology, and cardiovascular research, laying the foundation for his future contributions to medical biotechnology.​

Professional Experience

Dr. Momtazi-Borojeni has held various research and academic positions, including roles as a genomics lab expert at the Biotechnology Research Institute in Esfahan and as a part-time researcher at the Pharmaceutical Sciences Research Center of Isfahan University of Medical Sciences. He has also taught courses in cellular and molecular biology, genetic engineering, and bioinformatics at Isfahan University and Islamic Azad University, Neyshabur branch. Currently, he serves as an Assistant Professor at Neyshabur University of Medical Sciences, where he continues to advance research in medical biotechnology.​

Research Interests

Dr. Momtazi-Borojeni’s research interests encompass nanomedicine, immunotherapy, and phytomedicine, with a particular focus on developing innovative treatments for cardiovascular and metabolic diseases. His work on PCSK9-targeted therapies, including vaccine development and siRNA delivery systems, aims to provide alternative strategies for managing hypercholesterolemia and atherosclerosis. Additionally, he explores the therapeutic potential of natural compounds and bioinformatics approaches to identify novel drug targets and understand disease mechanisms.​

Research Skills

Dr. Momtazi-Borojeni possesses a diverse skill set that includes expertise in nanotechnology-based drug delivery, molecular biology techniques, immunological assays, and bioinformatics analysis. His proficiency in designing and characterizing nanoliposomes, conducting in vivo studies, and analyzing gene expression profiles enables him to undertake complex research projects that bridge multiple disciplines. His collaborative work with international researchers further demonstrates his ability to contribute to multidisciplinary teams and advance scientific knowledge.​

Awards and Honors

While specific awards and honors are not detailed in the provided information, Dr. Momtazi-Borojeni’s extensive publication record and citation metrics reflect his significant impact on the field of medical biotechnology. His research has been published in reputable journals, and his contributions to the development of PCSK9-targeted therapies have garnered international recognition. His active participation in scientific communities and collaborations with researchers worldwide underscore his commitment to advancing medical science.​

Conclusion

Dr. Amir Abbas Momtazi-Borojeni’s extensive research in medical biotechnology, particularly in the areas of nanomedicine and immunotherapy, positions him as a strong candidate for the Best Researcher Award. His innovative approaches to treating cardiovascular and metabolic diseases, combined with his interdisciplinary expertise and collaborative spirit, have significantly advanced the field. While specific awards and honors are not listed, his prolific publication record and international collaborations attest to his contributions to medical science. Continued support for his research endeavors will likely yield further breakthroughs in therapeutic strategies and enhance our understanding of complex diseases.​

Publications Top Notes

  1. Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades?

    • Authors: E. Abdollahi, A.A. Momtazi, T.P. Johnston, A. Sahebkar

    • Year: 2018

    • Citations: 302

  2. Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial

    • Authors: Y. Panahi, N. Khalili, E. Sahebi, S. Namazi, L.E. Simental-Mendía, M. Majeed, A. Sahebkar

    • Year: 2018

    • Citations: 257

  3. Curcumin as a MicroRNA regulator in cancer: a review

    • Authors: A.A. Momtazi, F. Shahabipour, S. Khatibi, T.P. Johnston, M. Pirro, A. Sahebkar

    • Year: 2016

    • Citations: 256

  4. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus

    • Authors: A.A. Momtazi-Borojeni, S.M. Haftcheshmeh, S.A. Esmaeili, T.P. Johnston, A. Sahebkar

    • Year: 2018

    • Citations: 233

  5. Isolation, identification, and characterization of cancer stem cells: A review

    • Authors: M.R. Abbaszadegan, V. Bagheri, M.S. Razavi, A.A. Momtazi, A. Sahebkar

    • Year: 2017

    • Citations: 228

  6. Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity

    • Authors: R. Rezaee, A.A. Momtazi, A. Monemi, A. Sahebkar

    • Year: 2017

    • Citations: 199

  7. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease

    • Authors: A.S. Moghaddam, J.T. Afshari, S.A. Esmaeili, E. Saburi, Z. Joneidi, A. Sahebkar

    • Year: 2019

    • Citations: 196

  8. A review on the pharmacology and toxicology of steviol glycosides extracted from Stevia rebaudiana

    • Authors: A. Abbas Momtazi-Borojeni, S.A. Esmaeili, E. Abdollahi, A. Sahebkar

    • Year: 2017

    • Citations: 192

  9. Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases

    • Authors: A.A. Momtazi, G. Derosa, P. Maffioli, M. Banach, A. Sahebkar

    • Year: 2016

    • Citations: 186

  10. Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile

    • Authors: A. Abbas Momtazi, A. Sahebkar

    • Year: 2016

    • Citations: 178

Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Published on by WSA Awards

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Fu Xiaocong | Molecular Biology | Best Innovation Award

Published on by WSA Awards

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.

Vipin Parkash | Biological Sciences | Outstanding Scientist Award

Published on by WSA Awards

Dr. Vipin Parkash | Biological Sciences | Outstanding Scientist Award

Scientist F & OIC & Prog. Coordinator (M.Sc. & Ph.D. Forestry) from ICFRE-Forest Research Institute, India

Dr. Vipin Parkash is an eminent Indian scientist and academician specializing in forest pathology, mycology, and microbial ecology, with a focus on mycorrhizal associations. Currently serving as Scientist-F and Officer-in-Charge of the Forest Pathology Section at the Forest Research Institute (Deemed University), Dehradun, he also holds the role of Programme Coordinator for M.Sc. and Ph.D. Forestry. With a career spanning over two decades, Dr. Parkash has significantly contributed to the domains of mycorrhizal ecology, ethnobotany, and soil microbiology. His scholarly impact is reflected in a strong publication record, with an h-index of 18 and i10-index of 32, and recognition across academic platforms such as Scopus, Google Scholar, ResearchGate, and LiveDNA. He has guided numerous Ph.D., Postdoctoral, M.Phil., and postgraduate students, cementing his reputation as a dedicated mentor. His interdisciplinary expertise includes plant-microbe interactions, biocontrol, and ecological restoration. Dr. Parkash is known for his extensive fieldwork, especially in ethnobotanical surveys across remote areas in Himachal Pradesh and Northeast India. His work is both research-intensive and practice-oriented, bridging the gap between microbiological research and forest ecosystem management. His lifelong commitment to forest protection and microbial research continues to shape forestry education and applied science in India.

Professional Profile

Education

Dr. Vipin Parkash possesses a rich and diverse academic background rooted in life sciences and specialized forestry disciplines. His educational journey began in Himachal Pradesh, where he completed his matriculation in 1992, securing the first position. He pursued a Bachelor of Science (B.Sc. Medical) from Himachal Pradesh University, Shimla in 1997, majoring in Chemistry, Botany, and Zoology, again achieving a first-class distinction. Advancing his academic interests, he earned his Master of Science (M.Sc.) in Botany from HNB Garhwal University, Srinagar in 1999, graduating with top honors and completing a dissertation focused on Ethnobotany and Plant Systematics. His academic excellence continued with a Doctor of Philosophy (Ph.D.) in Botany (specializing in Mycology and Soil Microbiology) from Kurukshetra University in 2004. His Ph.D. thesis, titled “Mycorrhizal studies on some ethnobotanical plants of Himachal Pradesh”, was conducted under the supervision of Prof. Ashok Aggarwal, reflecting an early and continued commitment to microbial-plant interactions. Dr. Parkash also qualified for the prestigious CSIR-UGC NET-JRF in 2000 and earned a Certificate Course in German in 2004. His strong educational foundation has laid the groundwork for his prolific research in forest pathology, microbial ecology, and sustainable forestry practices across India.

Professional Experience

Dr. Vipin Parkash has over two decades of diverse professional experience encompassing scientific research, academic instruction, and institutional leadership. He currently serves as Scientist-F and Officer-in-Charge of the Forest Pathology Section at the Forest Research Institute (Deemed University), Dehradun, where he is also the Programme Coordinator for M.Sc. and Ph.D. Forestry programmes. His academic career began with teaching postgraduate students in Botany, Microbiology, and Forestry at institutions such as Kurukshetra University and the Shoolini Institute of Life Sciences & Business Management in Himachal Pradesh. Over the years, he has developed and led numerous academic courses in forest protection, wood microbiology, and microbial ecology. Dr. Parkash has worked extensively in the field as a CSIR Junior Research Fellow (JRF) and Senior Research Fellow (SRF), conducting vital research in Mycology and Soil Microbiology at Kurukshetra University. His role included hands-on work with VAM fungi, microbial interaction studies, and propagation of medicinal plants in vitro. In addition to research and teaching, he has provided academic supervision for numerous Ph.D., Postdoctoral, M.Phil., and M.Sc. students, with several theses awarded under his mentorship. His career reflects a blend of field-based scientific inquiry and academic excellence, establishing him as a pillar in Indian forest microbiology and higher education.

Research Interests

Dr. Vipin Parkash’s research interests lie at the intersection of forest microbiology, plant-microbe interactions, and ecological restoration. His primary focus has been on arbuscular mycorrhizal (AM/VAM) fungi and their symbiotic relationships with ethnobotanical and forest plants, particularly within the Indian Himalayan and Northeastern regions. He is deeply involved in exploring the microbial ecology of rhizospheric soil and how these microbial communities contribute to plant health, growth, and secondary metabolite production. His doctoral and ongoing research examine the roles of mycorrhizal associations in plant conservation and bio-inoculant development. He is also interested in soil microbiology and mycology, particularly the diversity and taxonomy of wood-decaying fungi, endophytes, and actinobacteria. His work has expanded to include biocontrol of plant pathogens using microbial inoculants, biosynthesis of nanoparticles from macrofungi, and the development of microbial technologies for bioremediation of contaminated soils. Dr. Parkash’s research emphasizes sustainability and the ecological importance of fungi in forest ecosystems. His integration of field surveys, lab-based microbial isolation, and biotechnological applications reflects a holistic approach to studying forest ecosystems. With an evolving interest in bioactive compound extraction and microbial consortia, his work continues to contribute to both basic research and applied forestry sciences.

Research Skills

Dr. Vipin Parkash possesses a wide array of advanced research skills, particularly in forest microbiology, plant-microbe interactions, and soil microbial ecology. His expertise spans mycorrhizal taxonomy and classification, with a specialization in arbuscular mycorrhizae (AM/VAM fungi) and their ecological dynamics within the rhizosphere. He is highly skilled in conducting ethnobotanical surveys and field sampling in remote, biodiversity-rich regions, especially in Himachal Pradesh and Northeast India. Dr. Parkash has practical experience in isolating and identifying endophytes, actinobacteria, and wood-decaying fungi, as well as assessing their biocontrol potential against pathogenic microorganisms. In the lab, he is proficient in Polyacrylamide Gel Electrophoresis (PAGE) for strain differentiation and has applied in vitro propagation techniques to study plant-microbe interactions, particularly in medicinal plants like Rauvolfia serpentina. His research also involves microbial culture techniques, soil analysis, and the development of bio-inoculants and biofertilizers. Additionally, he has led projects on nanoparticle biosynthesis using fungi and evaluated their efficacy in controlling root-rot pathogens. His work integrates microbiological experimentation with biotechnology tools for sustainable forestry practices. With deep experience in guiding postgraduates and doctoral research, Dr. Parkash also demonstrates strong mentoring and data analysis capabilities, making him a highly competent and versatile researcher in forest ecosystem studies.

Awards and Honors

Dr. Vipin Parkash’s academic and research career is decorated with numerous accolades that reflect his dedication to forestry research and microbiology. He qualified for the prestigious CSIR-UGC NET with Junior Research Fellowship (JRF) in December 2000, a testament to his academic excellence and research aptitude at an early stage. Throughout his career, Dr. Parkash has maintained a strong presence in scholarly circles, with an impressive h-index of 18 and i10-index of 32, as per Google Scholar, highlighting the significant impact of his scientific publications. He has been an active and longstanding member of LIVE DNA since June 2010, and his global research profile is maintained through platforms like ORCID, ResearchGate, Scopus, and Google Scholar. His contributions to science and higher education have been widely acknowledged through his roles as Programme Coordinator at FRI (Deemed University), peer reviewer, research guide, and mentor to postgraduate and doctoral scholars. Many of his Ph.D. and M.Phil. students have received national fellowships such as CSIR-UGC NET, reflecting the high quality of mentorship he provides. His continued service in both academic and research domains under the Ministry of Environment & Forests, Government of India, has further solidified his standing as a distinguished scientist in forest pathology and microbial ecology.

Conclusion

Dr. Vipin Parkash stands as a distinguished scientist, educator, and research mentor whose contributions have significantly shaped the fields of forest microbiology and plant-microbe ecology in India. With more than two decades of experience in both research and teaching, he has consistently advanced our understanding of microbial symbiosis, bio-inoculants, and ecological restoration techniques. His academic journey from the remote hills of Himachal Pradesh to becoming Scientist-F and Programme Coordinator at the prestigious Forest Research Institute (Deemed University) showcases his dedication, resilience, and scientific rigor. His prolific output, marked by a substantial citation record and high-impact publications, reflects the depth and relevance of his research. He has not only contributed to academic scholarship but also played a transformative role in mentoring the next generation of researchers, having guided numerous Ph.D., M.Phil., and postgraduate theses. His work continues to influence policy, education, and sustainable forest management practices in India. Through his commitment to academic excellence, field-based inquiry, and interdisciplinary research, Dr. Parkash exemplifies the role of a scientist whose work bridges traditional knowledge and modern science, ensuring a greener and more resilient future for forest ecosystems.

Publications Top Notes

  • Title: Synthesis and antifungal activity of some new 3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromones
    Authors: O. Prakash, R. Kumar, V. Parkash
    Year: 2008
    Citations: 251

  • Title: Traditional uses of ethnomedicinal plants of lower foot-hills of Himachal Pradesh-I
    Authors: V. Parkash, A. Aggarwal
    Year: 2010
    Citations: 75

  • Title: Effect of elevated carbon dioxide on growth and development of Santalum album L. seedlings inoculated with plant growth promoting microorganisms in Open Top Chambers
    Authors: V. Prakash, K. Hunney, H. Singh
    Year: 2022
    Citations: 63

  • Title: Biogenic synthesis: A sustainable approach for nanoparticles synthesis mediated by fungi
    Authors: A. Chauhan, J. Anand, V. Parkash, N. Rai
    Year: 2023
    Citations: 50

  • Title: Effect of bioinoculants and superphosphate fertilizer on the growth and yield of broccoli (Brassica oleracea L. var. italica Plenck)
    Authors: A. Tanwar, A. Aggarwal, V. Parkash
    Year: 2014
    Citations: 45

  • Title: Screening and selection of efficient host and sugarcane bagasse as substrate for mass multiplication of Funneliformis mosseae
    Authors: A. Tanwar, A. Aggarwal, A. Yadav, V. Parkash
    Year: 2013
    Citations: 42

  • Title: A checklist of gilled mushrooms (Basidiomycota: Agaricomycetes) with diversity analysis in Hollongapar Gibbon Wildlife Sanctuary, Assam, India
    Authors: G. Gogoi, V. Parkash
    Year: 2015
    Citations: 36

  • Title: Arbuscular mycorrhizal fungal dynamics in the rhizospheric soil of five medicinal plant species
    Authors: A. Kumar, C. Mangla, A. Aggarwal, V. Parkash
    Year: 2010
    Citations: 33

  • Title: Symbiotic and synergistic efficacy of endomycorrhizae with Dendrocalamus strictus L.
    Authors: V. Parkash, S. Sharma, A. Aggarwal
    Year: 2011
    Citations: 31

  • Title: Diversity of Gasteroid Fungi (Basidiomycota) in Hollongapar Gibbon Wildlife Sanctuary, Jorhat, Assam, India
    Authors: G. Gogoi, P. Vipin
    Year: 2015
    Citations: 30

 

 

Atakan Koc | Biological Sciences | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Atakan Koc | Agricultural and Biological Sciences | Best Researcher Award

Animal Scientist From Aydın Adnan Menderes University, Turkey

Atakan Koç is a distinguished professor in animal science at Aydın Adnan Menderes University, Türkiye. With over three decades of experience, he specializes in cattle breeding, milk production, fertility, and quality improvement. His expertise extends to sustainable livestock management, camelid research, and dairy production systems. Koç has held various academic and administrative positions, including head of the department and director of research centers. He is actively involved in supervising PhD and MSc theses, contributing to advancing animal science research. As a member of multiple scientific organizations, including ISOCARD, he promotes knowledge exchange and collaboration. His extensive publications and leadership in international and national research projects reflect his dedication to improving livestock production efficiency and quality.

Professional Profile

Education

Atakan Koç holds a diverse and comprehensive educational background in animal science. He earned his PhD from Adnan Menderes University in Türkiye (1997-2001), focusing on genetic and phenotypic parameter estimates related to fertility and milk yield in Holstein dairy cattle. Prior to that, he completed his MSc at The University of Melbourne, Australia (1994-1997), with a thesis on genetic improvement in beef cattle and breeding program development for both Dookie Agricultural College and Türkiye. His academic journey began with a BSc from Ankara University (1987-1991), where he specialized in animal science. Koç’s international academic exposure has significantly contributed to his expertise in cattle genetics, dairy production, and breeding programs, laying the foundation for his impactful research and teaching career.

Professional Experience

Atakan Koç has a distinguished professional career in academia and research. He is currently a professor at Aydın Adnan Menderes University, Faculty of Agriculture, Department of Animal Science. His previous roles include associate professor and assistant professor at the same institution. Additionally, he served as a research assistant at Trakya University and later at Aydın Adnan Menderes University from 1992 to 2003. Koç also gained international experience through participation in a cattle production course in Sefhayim, Israel, and his MSc studies in Australia. His administrative roles include Head of Department and Director of Research and Application Centers, contributing to academic leadership and the advancement of animal science education and research.

Research Interests

Atakan Koç’s research interests are deeply rooted in animal science, with a primary focus on dairy and beef cattle breeding, milk yield improvement, and milk quality assessment. His work explores genetic parameters, somatic cell count, fertility traits, and carcass quality. Additionally, he has a keen interest in sustainable livestock management, including camel breeding and dairy production systems. Koç is actively involved in projects related to camel milk production, investigating its microbiological and physicochemical properties. His interests also extend to the application of artificial intelligence in livestock farming and evaluating the behavioral characteristics of cattle under different environmental conditions, contributing to improved production efficiency and animal welfare.

Research Skills

Atakan Koç possesses a robust skill set in animal science research, encompassing quantitative genetics, breeding program design, and statistical modeling for livestock data analysis. He is proficient in evaluating milk yield, fertility traits, and somatic cell count in dairy cattle. His technical expertise includes conducting large-scale field studies, analyzing carcass and meat quality traits, and assessing the impact of environmental factors on livestock production. Koç is also skilled in scientific writing, project management, and supervising research theses. His collaborative work with international teams demonstrates his ability to lead and contribute to large-scale research initiatives, utilizing modern methodologies for data collection and analysis.

Awards and Honors

Atakan Koç’s contributions to animal science have earned him recognition and prestigious honors. He has received accolades for his role in various national and international scientific projects. As the coordinator and researcher in projects supported by higher education institutions, he has been acknowledged for advancing dairy production and improving cattle breeding practices. His membership in ISOCARD and board membership in TMMOB Chamber of Agricultural Engineers highlight his influence in the scientific community. Additionally, Koç’s editorial role in the Journal of Animal Production reflects his standing as a respected figure in agricultural research, contributing to knowledge dissemination and scholarly excellence.

Conclusion

Atakan Koç is a leading figure in animal science, renowned for his expertise in cattle breeding, dairy production, and livestock management. His academic journey, marked by international education and research collaborations, has shaped his impactful career. Through his extensive publications, supervision of research theses, and involvement in large-scale projects, Koç has significantly contributed to the field. His dedication to improving milk quality, livestock productivity, and sustainable farming practices reflects his commitment to advancing agricultural science. With a distinguished career, he continues to influence the scientific community, fostering innovation and promoting research excellence in animal science.

Publications Top Notes

  1. Effect of Changes in Farm Management on the Yield and Constituents, Microbiological Quality, Somatic Cell Count and Fatty Acid Profile of the Camel Milk

    • Authors: Atakan Koç, Selda Bulca, Alkan Çağlı, Selma Büyükkılıç Beyzi, Bernard Faye, Gaukhar Konuspayeva, Mehmet Ulaş Çınar
    • Year: 2025

  2. Growth Performance, Body Measurements and Live Weight Estimation of Tülü (Bactrian × Dromedary F1) Calves from Birth to Six Months of Age

    • Authors: Atakan Koç, Alkan Çağlı
    • Year: 2025

  3. Bursa İli Karacabey İlçesinde Özel Bir İşletmede Yetiştirilen Simmental (Fleckvieh) Irkı Sığırların Dış Görünüş Özelliklerinin Değerlendirilmesi

    • Authors: Nazif Uzun, Atakan Koç
    • Year: 2024

  4. Type Traits of Primiparous Holstein-Friesian and Red-Holstein Cows Raised Together in a Farm in Aydın Province

    • Authors: Frederic Ndihokubwayo, Atakan Koç
    • Year: 2024

  5. Type Traits of Holstein-Friesian and Red-Holstein Cows Raised Together in a Private Farm in Aydın Province

    • Authors: Atakan Koç, Frederic Ndihokubwayo
    • Year: 2024

  6. Breeding Pure and Crossbreeds of European Cattle Breeds for Milk Production Improvement under Tropical Climate Conditions—a Review

    • Authors: Frederic Ndihokubwayo, Atakan Koç
    • Year: 2024

  7. A Research on Fertility, Herd Life, Milk Production and Milk Quality Characteristics of Simmental (Fleckvieh) Cows: 1. Reproduction, Herd Life and Milk Production Characteristics

    • Authors: Atakan Koç, Mehmet Öner
    • Year: 2023

  8. A Research on Fertility, Herd Life, Milk Production and Milk Quality Characteristics of Simmental (Fleckvieh) Cows: 2. Milk Quality

    • Authors: Atakan Koç, Mehmet Öner
    • Year: 2023

  9. Camel Milk Production System in Türkiye

    • Authors: Atakan Koç
    • Year: 2022

  10. A Study on the Changes of Colostrum Quality, Milk Constituents and Somatic Cell Count after Calving in Holstein Friesian Cows

  • Authors: Atakan Koç, Berkay Gaser
  • Year: 2022
  1. Süt Devesi Yetiştiriciliği Bakım-Yönetim Kılavuzu (Book)
  • Authors: Bernard Faye, Gaukhar Konuspayeva, Atakan Koç
  • Year: 2021
  1. A Study on Milk Yield, Fertility and Milk Quality Characteristics of Primiparous Red-Holstein and Holstein-Friesian Cows
  • Authors: Atakan Koç, Ramazan Gürses
  • Year: 2020
  1. Milk Yield, Reproduction and Milk Quality Characteristics of Simmental and Red-Holstein Cattle Raised at a Dairy Farm in Aydın Province: 2. Milk Quality
  • Authors: Atakan Koç, Çağrı Arı
  • Year: 2020
  1. Milk Yield, Reproduction and Milk Quality Characteristics of Simmental and Red-Holstein Cattle Raised in a Dairy Farm in Aydın Province: 1. Reproduction and Milk Yield
  • Authors: Atakan Koç, Çağrı Arı
  • Year: 2020
  1. Transglutaminaz Enziminin Deve Sütünden Üretilen Yoğurdun Bazı Özellikleri Üzerine Etkisi
  • Authors: Selda Bulca, Fahriye Ümüt, Atakan Koç
  • Year: 2020
  1. Deve Sütü: Yoğurt Üretiminde Kullanılacak Yeni Bir Protein Kaynağı
  • Authors: Selda Bulca, Atakan Koç
  • Year: 2020
  1. MONTHLY CHANGES OF BEHAVIORAL CHARACTERISTICS IN HOLSTEIN-FRIESIAN, BROWN SWISS AND SIMMENTAL BULLS
  • Authors: Atakan Koç
  • Year: 2019
  1. Develerde Karkas ve Et Kalite Özellikleri
  • Authors: Abdullah Bülbül, Atakan Koç
  • Year: 2018
  1. Siyah–Alaca, Esmer ve Simmental Tosunların Besi Performansı, Karkas ve Et Kalite Özellikleri
  • Authors: Eray Çatikkas, Atakan Koç
  • Year: 2017
  1. Effects of Somatic Cell Count and Various Environmental Factors on Milk Yield and Foremilk Constituents of Red-Holstein Cows
  • Authors: Atakan Koç
  • Year: 2015
  1. A Research on Milk Yield, Persistency, Milk Constituents and Somatic Cell Count of Red Holstein Cows Raised under Mediterranean Climatic Conditions
  • Authors: Yilmaz H., Koç A.
  • Year: 2013
  1. Short Communication: Effects of Some Environmental Factors and Extended Calving Interval on Milk Yield of Red Holstein Cows
  • Authors: Koç A.
  • Year: 2012
  1. A Study of the Reproductive Performance, Milk Yield, Milk Constituents, and Somatic Cell Count of Holstein-Friesian and Montbeliarde Cows
  • Authors: Koç A.
  • Year: 2011
  1. Food Safety at the Dairy Farm Level: Knowledge, Practices and Attitudes of Farmers
  • Authors: Armagan G., Koç A., Ozden A.
  • Year: 2009
  1. Some Factors Influencing Milk Somatic Cell Count of Holstein Friesian and Brown Swiss Cows under the Mediterranean Climatic Conditions
  • Authors: Koç A., Kizilkaya K.
  • Year: 2009
  1. Analysis of Repeated Milk Somatic Cell Count of Holstein-Friesian Cows Raised in Mediterranean Climatic Conditions
  • Authors: Koç A.
  • Year: 2006

Yanan Jiang | Pharmaceutical Science | Best Researcher Award

Published on by WSA Awards

Prof. Yanan Jiang | Pharmaceutical Science | Best Researcher Award

Professor at Harbin Medical University, China

Dr. Yanan Jiang is a Professor at Harbin Medical University, where she has been actively contributing to the field of pharmacology through impactful research and academic leadership. Her work primarily focuses on understanding the mechanisms of arsenic trioxide, therapeutic targets for cardiac injury, and the bioinformatics analysis of tumor and cardiovascular disease targets. With a robust academic foundation and over 26 SCI-indexed publications as the first or corresponding author, Dr. Jiang has established herself as a multidisciplinary researcher. She has secured funding for eight research projects, including prestigious grants from the National Natural Science Foundation of China. Additionally, Dr. Jiang serves on the editorial board of Scientific Reports and as a guest editor for four SCI journals. Her career reflects a balance of research innovation, academic excellence, and leadership in the global scientific community.

Professional Profile

Education

Dr. Jiang holds a Ph.D. in Pharmacology from Harbin Medical University, which she completed in December 2016. Her doctoral research laid the foundation for her current focus on molecular mechanisms in pharmacology and bioinformatics. Prior to this, she earned a Bachelor of Science in Traditional Chinese Medicine from the same university in 2010. This dual educational background integrates modern pharmacological techniques with traditional Chinese medicinal principles, enabling her to adopt a unique and comprehensive approach in her research. Her academic credentials highlight a commitment to understanding and innovating within pharmacological sciences.

Professional Experience

Dr. Jiang began her academic career as a Lecturer at Harbin Medical University in 2017. She was later promoted to Associate Professor, a role she held from 2017 to 2023, during which she also pursued a postdoctoral fellowship focusing on bioinformatics. Her postdoctoral research enhanced her expertise in utilizing computational approaches to study tumor and cardiovascular disease mechanisms. In September 2023, Dr. Jiang was appointed Professor at Harbin Medical University, a position that underscores her leadership and research excellence. Over the years, she has played a pivotal role in advancing pharmacology and bioinformatics, reflecting her versatility and dedication to interdisciplinary research.

Research Interests

Dr. Jiang’s research interests center around pharmacology, particularly the mechanisms and therapeutic applications of arsenic trioxide. She investigates the molecular pathways of cardiac injury and explores potential therapeutic targets to mitigate its impact. Additionally, she applies bioinformatics to analyze tumor and cardiovascular disease mechanisms, identifying novel biomarkers and therapeutic targets. Her multidisciplinary approach bridges traditional pharmacology and cutting-edge computational techniques, enabling the development of innovative treatment strategies. Dr. Jiang’s research not only contributes to the fundamental understanding of disease mechanisms but also holds significant translational potential for clinical applications.

Research Skills

Dr. Jiang possesses a diverse skill set that includes molecular pharmacology, bioinformatics, and experimental design for preclinical studies. Her expertise extends to the computational analysis of large datasets to identify disease biomarkers and therapeutic targets. She is proficient in leading complex, multi-institutional research projects, as evidenced by her role as principal investigator for eight funded studies. Her ability to integrate experimental and computational methods enhances her capability to tackle multifaceted scientific questions. Furthermore, Dr. Jiang’s editorial experience with renowned journals equips her with advanced skills in peer review, scientific communication, and publication management.

Awards and Honors

Dr. Jiang has been the recipient of multiple prestigious awards and honors that reflect her academic and research excellence. She has been awarded competitive grants, including those from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting her ability to attract substantial research funding. Her editorial roles with Scientific Reports and other SCI-indexed journals underscore her recognition as a leading expert in her field. These accolades, combined with her promotion to Professor at a young age, illustrate her significant contributions to pharmacology and bioinformatics, positioning her as a distinguished researcher in the scientific community.

Conclusion

Dr. Yanan Jiang is a highly competitive candidate for the Best Researcher Award, given her strong academic trajectory, robust research output, and success in securing funding. Her multidisciplinary expertise in pharmacology and bioinformatics, combined with her leadership roles in journals, underlines her prominence in her field. To further solidify her candidacy, she could emphasize her international collaborations, citation metrics, and mentorship contributions. Nonetheless, her accomplishments and expertise align well with the criteria for this award, making her a worthy contender.

Publication Top Notes

  1. Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease
    Authors: Shen, X., Shi, C., Xu, J., … Jiang, Y., Sun, H.
    Year: 2024
  2. Comprehensive characterization of long QT syndrome-associated genes in cancer and development of a robust prognosis model
    Authors: Xu, J., Wen, Z., She, Y., … Wang, S., Jiang, Y.
    Year: 2024
  3. Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity
    Author: Jiang, Y.
    Year: 2024
  4. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
    Authors: Jiang, Y., Shen, X., Zhi, F., … Yang, B., Bai, Y.
    Year: 2023
    Citations: 15
  5. Correction: The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
    Authors: Shen, X., Zhi, F., Shi, C., … Bai, Y., Yang, B.
    Year: 2023
    Citations: 1
  6. The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
    Authors: Shen, X., Zhi, F., Shi, C., … Jiang, Y., Yang, B.
    Year: 2023
    Citations: 10
  7. Open a new epoch of arsenic trioxide investigation: ATOdb
    Authors: Jiang, Y., Li, J., Liu, Y., … Shao, T., Xu, Y.
    Year: 2023
  8. Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia
    Authors: Luo, K., Qian, Z., Jiang, Y., … Jin, S., Shang, D.
    Year: 2023
    Citations: 16
  9. From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis
    Authors: Zhangdi, H., Jiang, Y., Gao, Y., … Geng, X., Jin, S.
    Year: 2023
    Citations: 2
  10. Research Progress of New Dosage Forms of Arsenic Trioxide | 三氧化二砷新剂型的研究进展
    Authors: Liao, R., Shi, C., Fu, W., … Zhi, F., Jiang, Y.
    Year: 2023
    Citations: 1

 

 

 

Ania Rashidpour | Biotechnology | Best Researcher Award

Published on by WSA Awards

Ania Rashidpour | Biotechnology | Best Researcher Award

Dr. Ania Rashidpour , Universitat de Barcelona, Spain.

Publication profile

Scopus

Education and Experience

  • 🎓 Doctorate in Biotechnology – University of Barcelona, 2024
  • 🧑‍🏫 Researcher – Multiple biotechnology projects focusing on sustainable solutions
  • 🔬 Research Assistant – Biotechnology Lab, University of Barcelona
  • 🌿 Masters in Biotechnology – University of Tehran
  • 📚 Bachelor’s in Molecular Biology – University of Tehran

Suitability For The Award

Dr. Ania Rashidpour, a recent PhD graduate from the University of Barcelona, is a highly suitable candidate for the Best Researcher Award due to her academic excellence, research expertise in Biotechnology, and demonstrated commitment to advancing scientific knowledge. Her educational background, international exposure, and research accomplishments, as evident from the completion of her PhD, make her a strong contender for this prestigious award.

Professional Development (💼🔬)

Awards and Honors (🏆🎖️)

  • 🏆 Best PhD Thesis Award – University of Barcelona, 2024
  • 🏅 Biotechnology Research Excellence Award – International Science Conference, 2023
  • 🌟 Outstanding Young Researcher Award – University of Tehran, 2020
  • 🎖 Excellence in Biotechnology Award – National Biotechnology Symposium, 2019

Publications

Muhammad Asif Nawaz | Biotechnology | Best Researcher Award

Published on by WSA Awards

Muhammad Asif Nawaz: Biotechnology

👨‍🏫Muhammad Asif Nawaz an Assistant Professor at Shaheed BB ,University Department of Biotechnology , stands as a distinguished academic and researcher in the domain of Biochemistry. Holding a PhD from University of Karachi, their professional journey exemplifies dedication and expertise. 📚

🌐 Professional Profiles:

Academic and Professional Profile 🎓

Education:

Ph.D. in Biotechnology, University of Karachi, Karachi, Pakistan, 2015.Bachelor of Science (BS) in Biotechnology, University of Malakand, KPK, Pakistan, 2010.HSC (Pre-medical), Board of Intermediate and Secondary Education, Malakand, Pakistan, 2006.SSC (Science), Board of Intermediate and Secondary Education, Malakand, Pakistan, 2004.

Professional Experience:

Assistant Professor, Department of Biotechnology, Shaheed BB University, Sheringal Dir (Upper), Khyber-Pakhtunkhwa, Pakistan (since August 2015).Research Fellow, Dr. A. Q. Khan Institute of Biotechnology and Genetic Engineering (KIBGE), University of Karachi, Karachi, Pakistan (March 2014 – March 2015).

Research Interests:

Industrial Biotechnology, Enzymology, Medical Microbiology, Environmental Biology, Microbiology, Genetic Engineering

Training:

Short-term fellowship program related to wastewater treatment and sanitation by CAS-TWAS Centre of Excellence for Water and Environment (CAS-TWAS CEWE), Chinese Academy of Sciences (CAS) Beijing, China.

Accolades and Grants:

Received multiple project awards and grants from the Higher Education Commission (HEC) for various research projects related to cellulase production, pesticide residues, DNA polymorphism, avian parasites, and antimicrobial constituents.

Awards and Professional Affiliation 🏆

Research Fellowship: Received from Dr. A. Q. Khan Institute of Biotechnology and Genetic Engineering (KIBGE), University of Karachi, Karachi, Pakistan.Subscription Award: Awarded a one-year subscription of Nature by the International Council for Life Science (ICLS) at the ICLS-KIBGE conference on Science, Technology, and Engineering: Innovative, Yet Responsible.Lifetime Membership: Pakistan Biological Safety Association (PBSA).Membership: National Academy of Young Scientists.Membership: Biological Society of Pakistan.

Top Noted  Publications by Dr. Muhammad Asif Nawaz 📚🔍:

Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products

Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital

Assessment of microbial load of raw meat at abattoirs and retail outlets

Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) and Allium sativum (Garlic) in chick embryos

Selenium increases expression of HSP70 and antioxidant enzymes to lessen oxidative damage in Fincoal-type fluorosis

Outbreak of acute respiratory disease caused by human adenovirus type 7 in a military training camp in Shaanxi, China

Screening and characterization of new potentially probiotic lactobacilli from breast-fed healthy babies in Pakistan

Hantaviruses in rodents and humans, Xi’an, PR China

Molecular characterisation of the faecal microbiota in patients with type II diabetes